Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Chamouni

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Stomatology, Oral and Maxillofacial Surgery|February 12, 2022
Management of patients with inherited bleeding disorders in oral surgery: A 13-year experienceCécile Landart, Virginie Barbay, Pierre Chamouni, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 19, 2021
First observation of inhibitor development against efmoroctocog alfa in FrancePierre Chamouni, Virginie Barbay, Paul Billoir, et al.
Clinical Biochemistry|November 29, 2021
Factor XII deficiency evaluated by thrombin generation assayGuillaume Feugray, Fiston Kasonga, Pierre Chamouni, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 20, 2021
Evaluation of thrombin generation assay in factor XI deficiencyFiston Kasonga, Guillaume Feugray, Pierre Chamouni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 14, 2022
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxisBrigitte Tardy, Thierry Lambert, Pierre Chamouni, et al.
British Journal of Haematology|August 16, 2019
Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohortSéverine Bouttefroy, Sandrine Meunier, Vanessa Milien, et al.
Journal of Blood Medicine|March 17, 2021
The Hemarthrosis-Simulating Knee Model: A Useful Tool for Individualized Education in Patients with Hemophilia (GEFACET Study)Sophie le Doré, Nathalie Grinda, Emmanuelle Ferré, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2020
Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: Results from a prospective observational post-marketing studyJenny Goudemand, Françoise Bridey, Ségolène Claeyssens, et al.
European Journal of Haematology|April 19, 2022
Effectiveness of long-term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand diseaseLucia Rugeri, Annie Harroche, Yohan Repessé, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2022
Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment CentresPhilippe Gautier, Benoit Guillet, Marianne Sigaud, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Stomatology, Oral and Maxillofacial Surgery|February 12, 2022
Management of patients with inherited bleeding disorders in oral surgery: A 13-year experienceCécile Landart, Virginie Barbay, Pierre Chamouni, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 19, 2021
First observation of inhibitor development against efmoroctocog alfa in FrancePierre Chamouni, Virginie Barbay, Paul Billoir, et al.
Clinical Biochemistry|November 29, 2021
Factor XII deficiency evaluated by thrombin generation assayGuillaume Feugray, Fiston Kasonga, Pierre Chamouni, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 20, 2021
Evaluation of thrombin generation assay in factor XI deficiencyFiston Kasonga, Guillaume Feugray, Pierre Chamouni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 14, 2022
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxisBrigitte Tardy, Thierry Lambert, Pierre Chamouni, et al.
British Journal of Haematology|August 16, 2019
Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohortSéverine Bouttefroy, Sandrine Meunier, Vanessa Milien, et al.
Journal of Blood Medicine|March 17, 2021
The Hemarthrosis-Simulating Knee Model: A Useful Tool for Individualized Education in Patients with Hemophilia (GEFACET Study)Sophie le Doré, Nathalie Grinda, Emmanuelle Ferré, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2020
Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: Results from a prospective observational post-marketing studyJenny Goudemand, Françoise Bridey, Ségolène Claeyssens, et al.
European Journal of Haematology|April 19, 2022
Effectiveness of long-term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand diseaseLucia Rugeri, Annie Harroche, Yohan Repessé, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2022
Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment CentresPhilippe Gautier, Benoit Guillet, Marianne Sigaud, et al.
Pageof 2